<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41025694</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-4881</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>European journal of preventive cardiology</Title><ISOAbbreviation>Eur J Prev Cardiol</ISOAbbreviation></Journal><ArticleTitle>Effect of Structured Exercise Training on Chronotropic Incompetence in Patients with Heart Failure with preserved Ejection Fraction.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">zwaf628</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurjpc/zwaf628</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Chronotropic incompetence (CI) is common in heart failure with preserved ejection fraction (HFpEF) and contributes to reduced exercise tolerance. However, the effects of exercise training on CI in HFpEF remain unknown. We aimed to assess the effect of different exercise training intensities on chronotropic reserve in HFpEF.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a subanalysis of the OptimEx-Clin trial. Patients with HFpEF were randomized to high-intensity interval training (HIIT), moderate continuous training (MCT) or guideline control (GC). CI was assessed during cardiopulmonary exercise testing at baseline and 3 months. CI was defined as a chronotropic index &#x2264;0.62 in patients on negative chronotropic medications and &#x2264;0.80 in others.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 175 patients with HFpEF (66% female, mean age 70&#xb1;8 years), 144 completed follow-up. CI was present in 51% and was associated with lower peak oxygen uptake (16.5&#xb1;4.2 vs. 21.1&#xb1;5.2 mL/kg/min, p&lt;.001), lower peak workload (89&#xb1;28 vs. 116&#xb1;39 W, p&lt;.001), and poorer ventilatory efficiency (35.2&#xb1;7.1 vs. 32.6&#xb1;6.8, p=.014) at baseline. HIIT and MCT did not improve chronotropic index, %predicted peak heart rate, nor CI prevalence after 3 months (all p&gt;.500), and adjusting for negative chronotropic drug use did not change results. Nevertheless, HIIT and MCT improved V&#x307;O2peak and workload (p&lt;.001) versus GC, regardless of the presence of CI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In elderly patients with HFpEF, neither HIIT nor MCT during 3 months significantly improved chronotropic reserve or reduced CI prevalence, but exercise capacity was improved.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nasser</LastName><ForeName>Riwa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1330-2836</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital (UZA), Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verelst</LastName><ForeName>Faro R</ForeName><Initials>FR</Initials><Identifier Source="ORCID">0000-0001-9304-0922</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital (UZA), Edegem, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR Department, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1383-5715</Identifier><AffiliationInfo><Affiliation>Technical University of Munich, School of Medicine and Health, Department for Preventive Sports Medicine and Sports Cardiology, TUM University Hospital, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winzer</LastName><ForeName>Ephraim B</ForeName><Initials>EB</Initials><Identifier Source="ORCID">0000-0002-1752-8528</Identifier><AffiliationInfo><Affiliation>Heart Centre Dresden - University Hospital, Department of Internal Medicine and Cardiology, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckers</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-9135-110X</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation Sciences and Physiotherapy, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van De Heyning</LastName><ForeName>Caroline M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-4661-4732</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital (UZA), Edegem, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR Department, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wisl&#xf8;ff</LastName><ForeName>Ulrik</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-7211-3587</Identifier><AffiliationInfo><Affiliation>Cardiac Exercise Research Group, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieske</LastName><ForeName>Burkert</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6144-4380</Identifier><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Volker</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5090-9154</Identifier><AffiliationInfo><Affiliation>Heart Centre Dresden - University Hospital, Department of Internal Medicine and Cardiology, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halle</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6222-956X</Identifier><AffiliationInfo><Affiliation>Technical University of Munich, School of Medicine and Health, Department for Preventive Sports Medicine and Sports Cardiology, TUM University Hospital, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Craenenbroeck</LastName><ForeName>Emeline M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0001-7686-2668</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital (UZA), Edegem, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR Department, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gevaert</LastName><ForeName>Andreas B</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0002-1338-4133</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital (UZA), Edegem, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR Department, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Prev Cardiol</MedlineTA><NlmUniqueID>101564430</NlmUniqueID><ISSNLinking>2047-4873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>This subanalysis of the OptimEx-Clin trial investigated if exercise training had an effect on impaired increment of heart rate during exercise, a key feature in patients with HFpEF and an important determinant for cardiac output. In addition, the impact of patient characteristics on impaired heart rate increase is described in addition to the effects of different training intensities. Key FindingsBoth high-intensity interval training (HIIT) and moderate continuous training (MCT), improved overall exercise capacity in elderly HFpEF patients after three months, regardless of the presence CI.Despite improvements in exercise performance, neither HIIT nor MCT significantly improved chronotropic reserve in elderly patients with HFpEF.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HFpEF</Keyword><Keyword MajorTopicYN="N">beta blockers</Keyword><Keyword MajorTopicYN="N">chronotropic reserve</Keyword><Keyword MajorTopicYN="N">exercise capacity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>30</Day><Hour>8</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41025694</ArticleId><ArticleId IdType="doi">10.1093/eurjpc/zwaf628</ArticleId><ArticleId IdType="pii">8268741</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>